Showing results (21-30 of 745) with videos related to
Sort By:
Pageof 75
Case Reports in Endocrinology|April 16, 2020
Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous <i>APOC2</i> MutationMasako Ueda, Anna Wolska, Frances M Burke, et al.Journal of Lipid Research|January 26, 2017
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimeticsRichard L Dunbar, Harsh Goel, Sony Tuteja, et al.The American Journal of Medicine|July 31, 2012
Extended-release niacin acutely suppresses postprandial triglyceridemiaM Haris U Usman, Arman Qamar, Ramprasad Gadi, et al.Current Atherosclerosis Reports|February 16, 2016
Niacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part I: Alternative Niacin RegimensRichard L Dunbar, Harsh GoelCurrent Atherosclerosis Reports|March 3, 2016
Niacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part II: Novel Niacin MimeticsHarsh Goel, Richard L DunbarJournal of Cardiopulmonary Rehabilitation|April 18, 2006
High-density lipoprotein cholesterol therapies: the next frontier in lipid managementDanielle Duffy, Daniel J RaderCurrent Opinion in Cardiology|June 16, 2005
Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J RaderClinical Chemistry|April 1, 2008
Laboratory assessment of HDL heterogeneity and functionRajesh Movva, Daniel J RaderNature Reviews. Endocrinology|September 3, 2014
Dyslipidaemia: cardiovascular prevention--end of the road for niacin?Sony Tuteja, Daniel J RaderThe Lancet. Diabetes & Endocrinology|March 26, 2016
Recent advances in the pharmacological management of hypercholesterolaemiaEzim Ajufo, Daniel J RaderPageof 75